Literature DB >> 7783597

Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.

T Lagergård1, A Frisk, M Purvèn, L A Nilsson.   

Abstract

Serum bactericidal activity and phagocytic killing are two important mechanisms involved in the host defence against bacteria. Using some in vitro methods, serum bactericidal assay, phagocytic killing by polymorphonuclear leukocytes (PMN) and chemiluminescence, we have evaluated the significance of these mechanisms in the killing of Haemophilus ducreyi bacteria. Furthermore, induction of C3 conversion and deposition of immunoglobulins, C1q and C3, on the surface of bacteria was studied by crossed immunoelectrophoresis and ELISA, respectively. Transmission electron microscopy was employed to study internalization of bacteria by PMN. H. ducreyi and lipooligosaccharide preparations from these bacteria were able to induce conversion of complement factor C3 in normal human serum (NHS). Exposure of bacteria to NHS resulted in deposition of IgG, IgM and complement factors C1q and C3 on the surface of bacteria. H. ducreyi bacteria lost their viability when incubated with fresh but not inactivated normal serum at high concentrations, indicating that the bacteria are sensitive to the complement-dependent bactericidal activity of serum. There were some variations between different strains regarding their susceptibility to the bactericidal activity of NHS, but for eight strains tested, all of the bacteria exposed were not killed in medium containing up to 70% of fresh serum. Complement-mediated opsonophagocytic killing of H. ducreyi by PMN was more effective than complement-dependent bactericidal activity of fresh normal sera. Bacteria treated with heat inactivated immune sera, on the other hand, were as sensitive to the bactericidal effect of PMN as those treated with non-inactivated immune sera, indicating the role of antibodies in opsonophagocytosis. H. ducreyi bacteria were also killed by PMN in the absence of serum antibodies and complement. Using the chemiluminescence assay, H. ducreyi was shown to activate PMN in the absence of serum as well as after opsonization with complement and antibodies. Our results therefore indicate that both opsonic- and non-opsonic mechanisms are involved in the phagocytosis and the subsequent killing of H. ducreyi bacteria. Although both complement and antibodies enhance the ability of phagocytes to kill H. ducreyi, neither component is sufficient for effective killing of H. ducreyi.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783597

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  12 in total

1.  Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers.

Authors:  M E Bauer; M P Goheen; C A Townsend; S M Spinola
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line.

Authors:  G E Wood; S M Dutro; P A Totten
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Killing of dsrA mutants of Haemophilus ducreyi by normal human serum occurs via the classical complement pathway and is initiated by immunoglobulin M binding.

Authors:  Malikah Abdullah; Igor Nepluev; Galyna Afonina; Sanjay Ram; Peter Rice; William Cade; Christopher Elkins
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase.

Authors:  X Cortes-Bratti; E Chaves-Olarte; T Lagergård; M Thelestam
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

5.  Cloning, overexpression, purification, and immunobiology of an 85-kilodalton outer membrane protein from Haemophilus ducreyi.

Authors:  K L Thomas; I Leduc; B Olsen; C E Thomas; D W Cameron; C Elkins
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Neutropenia restores virulence to an attenuated Cu,Zn superoxide dismutase-deficient Haemophilus ducreyi strain in the swine model of chancroid.

Authors:  L R San Mateo; K L Toffer; P E Orndorff; T H Kawula
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes.

Authors:  Hinda J Ahmed; Catharina Johansson; Liselott A Svensson; Karin Ahlman; Margareta Verdrengh; Teresa Lagergård
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

8.  Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid A protects swine from a homologous but not a heterologous challenge.

Authors:  William G Fusco; Galyna Afonina; Igor Nepluev; Deborah M Cholon; Neelima Choudhary; Patricia A Routh; Glenn W Almond; Paul E Orndorff; Herman Staats; Marcia M Hobbs; Isabelle Leduc; Christopher Elkins
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

9.  A novel lectin, DltA, is required for expression of a full serum resistance phenotype in Haemophilus ducreyi.

Authors:  Isabelle Leduc; Patricia Richards; Crystal Davis; Birgit Schilling; Christopher Elkins
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

10.  Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.

Authors:  Galyna Afonina; Isabelle Leduc; Igor Nepluev; Chrystina Jeter; Patty Routh; Glen Almond; Paul E Orndorff; Marcia Hobbs; Christopher Elkins
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.